PALI (STOCKS)
Palisade Bio, Inc. Common Stock
$1.999600
+0.179600 (+9.87%)
Prev close: $1.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- J. D. Finley
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $329.15M
- Employees
- 8
- P/E (TTM)
- -1.34
- P/B (TTM)
- 2.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $1.28M |
| Operating Expenses | $18.06M |
| Operating Income/Loss | -$18.06M |
| Income/Loss From Continuing Operations After Tax | -$16.78M |
| Income/Loss From Continuing Operations Before Tax | -$16.78M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$16.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$16.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$16.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.30 |
| Diluted Earnings Per Share | -$0.30 |
| Basic Average Shares | 55,669,821 |
| Diluted Average Shares | 55,669,821 |
| Assets | $134.34M |
| Current Assets | $134.22M |
| Noncurrent Assets | $123.00K |
| Fixed Assets | $0.00 |
| Liabilities | $4.96M |
| Current Liabilities | $4.64M |
| Accounts Payable | $767.00K |
| Wages | $1.30M |
| Other Current Liabilities | $2.57M |
| Noncurrent Liabilities | $328.00K |
| Equity | $129.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $129.38M |
| Liabilities And Equity | $134.34M |
| Net Cash Flow From Operating Activities | -$10.85M |
| Net Cash Flow From Operating Activities, Continuing | -$10.85M |
| Net Cash Flow From Investing Activities | -$123.59M |
| Net Cash Flow From Investing Activities, Continuing | -$123.59M |
| Net Cash Flow From Financing Activities | $134.44M |
| Net Cash Flow From Financing Activities, Continuing | $134.44M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$16.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.78M |
| Other Comprehensive Income/Loss | $0.00 |